Association of n-3 polyunsaturated fatty acids with soluble thrombomodulin as a marker of endothelial damage: A cross-sectional pilot study

Journal of Cardiology

Volumn 64, Issue 4, 2014, Pages 312-317

  Kawauchi, Kenji ^a,b   Tani, Shigemasa ^a,b   Nagao, Ken ^a,b   Hirayama, Atsushi ^b  

^a SURUGADAI NIHON UNIVERSITY HOSPITAL   (Japan)

^b NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Atherosclerosis; Coronary risk factor; Endothelium; Fatty acids

Indexed keywords

AMYLOID A PROTEIN; C REACTIVE PROTEIN; DOCOSAHEXAENOIC ACID; FIBRINOGEN; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ICOSAPENTAENOIC ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OMEGA 3 FATTY ACID; THROMBOMODULIN; BIOLOGICAL MARKER;

ADULT; ARTICLE; BODY MASS; CHRONIC KIDNEY DISEASE; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY RISK; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE SEVERITY; DYSLIPIDEMIA; ENDOTHELIAL DYSFUNCTION; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; HYPERURICEMIA; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PILOT STUDY; SMOKING; URINARY EXCRETION; ATHEROSCLEROSIS; BLOOD; PATHOPHYSIOLOGY; RISK FACTOR; VASCULAR ENDOTHELIUM;

ATHEROSCLEROSIS; BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; RISK FACTORS; THROMBOMODULIN;

EID: 84926251869     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2014.02.004     Document Type: Article

References (28)

1. Kromhout D., Bosschieter E.B.de, Lezenne Coulander C. The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med 1985, 312:1205-1209.
2. Lavie C.J., Milani R.V., Mehra M.R., Ventura H.O. Omega-3 polyunsaturated fatty acids and cardiovascular diseases. J Am Coll Cardiol 2009, 54:585-594.
3. Mozaffarian D., Wu J.H. Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events. J Am Coll Cardiol 2011, 58:2047-2067.
4. Sadler J.E. Thrombomodulin structure and function. Thromb Haemost 1997, 78:392-395.
5. Maruyama I., Bell C.E., Majerus P.W. Thrombomodulin is found on endothelium of arteries, veins, capillaries, lymphatic, and on syncytiotrophoblast of human placenta. J Cell Biol 1985, 101:363-371.
6. Ishii H., Majerus P.W. Thrombomodulin is present in human plasma and urine. J Clin Invest 1985, 76:2178-2181.
7. Califano F., Giovanniello T., Pantone P., Campana E., Parlapiano C., Alegiani F., Vincentelli G.M., Turchetti P. Clinical importance of thrombomodulin serum levels. Eur Rev Med Pharmacol Sci 2000, 4:59-66.
8. Ishii H., Uchiyama H., Kazama M. Soluble thrombomodulin antigen in conditioned medium is increased by damage of endothelial cells. Thromb Haemost 1991, 65:618-623.
9. Seigneur M., Dufourcq P., Conri C., Constans J., Mercie P., Pruvost A., Boisseau M. Plasma thrombomodulin: new approach of endothelium damage. Int Angiol 1993, 12:355-359.
10. Imai E., Horio M., Nitta K., Yamagata K., Iseki K., Hara S., Ura N., Kiyohara Y., Hirakata H., Watanabe T., Moriyama T., Ando Y., Inaguma D., Narita I., Iso H., et al. Estimation of glomerular filtration rate by the MDRD study equation modified for Japanese patients with chronic kidney disease. Clin Exp Nephrol 2007, 11:41-50.
11. Sniderman A.D., Blank D., Zakarian R., Bergeron J., Frohlich J. Triglycerides and small dense LDL: the twin Achilles heels of the Friedewald formula. Clin Biochem 2003, 36:499-504.
12. Constans J., Conri C. Circulating markers of endothelial function in cardiovascular disease. Clin Chim Acta 2006, 368:33-47.
13. Blann A.D., Amiral J., McCollum C.N. Prognostic value of increased soluble thrombomodulin and increased soluble E-selectin in ischaemic heart disease. Eur J Haematol 1997, 59:115-120.
14. Olivot J.M., Labreuche J., Aiach M., Amarenco P. Soluble thrombomodulin and brain infarction: case-control and prospective study. Stroke 2004, 35:1946-1951.
15. Seigneur M., Boisseau M., Conri C., Lestage B., Amiral J., Constans J. Circulating endothelial markers and ischemic status in peripheral occlusive arterial disease. Nouv Rev Fr Hematol 1995, 37:171-173.
16. Salomaa V., Matei C., Aleksic N., Sansores-Garcia L., Folsom A.R., Juneja H., Park E., Wu K.K. Cross-sectional association of soluble thrombomodulin with mild peripheral artery disease; the ARIC study. Atherosclerosis risk in communities. Atherosclerosis 2001, 157:309-314.
17. Peter K., Nawroth P., Conradt C., Nordt T., Weiss T., Boehme M., Wunsch A., Allenberg J., Kübler W., Bode C. Circulating vascular cell adhesion molecule-1 correlates with the extent of human atherosclerosis in contrast to circulating intercellular adhesion molecule-1, E-selectin, P-selectin, and thrombomodulin. Arterioscler Thromb Vasc Biol 1997, 17:505-512.
18. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999, 340:115-126.
19. Nissen S.E., Tuzcu E.M., Schoenhagen P., Crowe T., Sasiela W.J., Tsai J., Orazem J., Magorien R.D., O'Shaughnessy C., Ganz P. Reversal of atherosclerosis with aggressive lipid lowering (REVERSAL) investigators statin therapy, LDL, cholesterol, C-reactive protein, and coronary artery disease. N Engl J Med 2005, 352:29-38.
20. Folsom A.R., Chambless L.E., Ballantyne C.M., Coresh J., Heiss G., Wu K.K., Boerwinkle E., Mosley T.H., Sorlie P., Diao G., Sharrett A.R. An assessment of incremental coronary risk prediction using C-reactive protein and other novel risk markers: the atherosclerosis risk in communities study. Arch Intern Med 2006, 166:1368-1373.
21. van Bussel B.C., Henry R.M., Schalkwijk C.G., Ferreira I., Feskens E.J., Streppel M.T., Smulders Y.M., Twisk J.W., Stehouwer C.D. Fish consumption in healthy adults is associated with decreased circulating biomarkers of endothelial dysfunction and inflammation during a 6-year follow-up. J Nutr 2011, 141:1719-1725.
22. Hjerkinn E.M., Seljeflot I., Ellingsen I., Berstad P., Hjermann I., Sandvik L., Arnesen H. Influence of long-term intervention with dietary counseling, long-chain n-3 fatty acid supplements, or both on circulating markers of endothelial activation in men with long-standing hyperlipidemia. Am J Clin Nutr 2005, 81:583-589.
23. Schiano V., Laurenzano E., Brevetti G., De Maio J.I., Lanero S., Scopacasa F., Chiariello M. Omega-3 polyunsaturated fatty acid in peripheral arterial disease: effect on lipid pattern, disease severity, inflammation profile, and endothelial function. Clin Nutr 2008, 27:241-247.
24. Satoh N., Shimatsu A., Kotani K., Sakane N., Yamada K., Suganami T., Kuzuya H., Ogawa Y. Purified eicosapentaenoic acid reduces small dense LDL, remnant lipoprotein particles, and C-reactive protein in metabolic syndrome. Diab Care 2007, 30:144-146.
25. Calder P.C. Polyunsaturated fatty acids and inflammatory processes: new twists in an old tale. Biochimie 2009, 91:791-795.
26. Seljeflot I., Tonstad S., Hjermann I., Arnesen H. Reduced expression of endothelial cell markers after 1 year treatment with simvastatin and atorvastatin in patients with coronary heart disease. Atherosclerosis 2002, 162:179-185.
27. Małyszko J., Małyszko J.S., Hryszko T., Myśliwiec M. Simvastain affects TAFI and thrombomodulin in CAPD patients. Thromb Haemost 2001, 86:930-931.
28. Ambrosi P., Aillaud M.F., Habib G., Kreitmann B., Métras D., Luccioni R., Bouvenot G., Juhan-Vague I. Fluvastatin decreases soluble thrombomodulin in cardiac transplant recipients. Thromb Haemost 2000, 83:46-48.